Adlai Nortye
CEO
AN
Adlai Nortye
en.adlainortye.com
Website unreachable since Oct 17, 2026
Adlai Nortye is a clinical-stage biopharmaceutical company focused on developing targeted therapies for various cancer types using precision medicine approaches. The company aims to improve treatment outcomes for patients with difficult-to-treat tumors by advancing its pipeline of novel drug candidates.
- Software Only
Updated 7 months ago
Funding
Raised to date
$40MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Okay, I understand. I will analyze the provided "original description" and "website content" (when available), and then generate a new startup description that adheres to the specified structure, content, and writing guidelines. I will focus on clarity, accuracy, and the use of appropriate technical terminology, while avoiding hype and unnecessary details. I will also ensure that the response is formatted correctly with the required XML tags.
- Let's begin.